This comprehensive guide provides researchers, scientists, and drug development professionals with a practical framework for successful cancer biomarker development.
This article provides a comprehensive guide to Bayesian adaptive methods within master protocol trials for drug development professionals.
This article provides a comprehensive examination of the core principles of cancer immunoediting and immune surveillance, tailored for researchers and drug development professionals.
This article provides a comprehensive overview of BMI-1 (B-cell-specific Moloney murine leukemia virus integration site 1) as a master regulator of cancer stem cell (CSC) stemness and a promising therapeutic...
This article provides a comprehensive examination of the Bladder Cancer-Associated Protein (BLCAP) gene as a novel biomarker for predicting patient response to CTLA-4 checkpoint inhibitor therapy.
This article provides a detailed comparative analysis of B-cell maturation antigen (BCMA)-targeted immunotherapies for relapsed/refractory multiple myeloma, focusing on chimeric antigen receptor T-cell (CAR-T) therapies and bispecific T-cell engagers (BiTEs).
This article provides a comprehensive review for researchers and drug development professionals on the emerging predictive roles of BCL2, FGFR3, and YAP1 in immunotherapy outcomes.
This article provides a comprehensive guide for researchers and drug development professionals on implementing automated image analysis for quantifying Cancer Stem Cell (CSC) biomarkers.
This article provides a comprehensive overview of the latest advances in targeting the immunosuppressive adenosine pathway within the tumor microenvironment (TME).
This comprehensive guide details the Aldefluor assay for detecting ALDH enzymatic activity, a key marker for stem and progenitor cells.